Beijing, China

Quan Du

This inventor holds 1 USPTO granted patent. Top assignee: Biomics Biotechnologies, Co., Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Quan Du. Retrieved from https://idiyas.com/inventor/quan-du-h5j8jcg5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in RNA Technology by Quan Du

Introduction

Quan Du is an accomplished inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of RNA molecules. His work focuses on creating stable double-stranded RNA molecules that can be utilized in various medical applications.

Latest Patents

Quan Du holds a patent for "Double-stranded RNA molecules with stability in mammalian body fluid, preparation and application thereof." This invention discloses the preparation and application of double-stranded RNA molecules that remain stable in mammalian body fluids. The RNA molecules are comprised solely of unmodified nucleotides. For the first time, this invention reveals the applications of these stable RNA molecules for immunotherapy and siRNA drug development. He has 1 patent to his name.

Career Highlights

Quan Du is currently employed at Biomics Biotechnologies, Co., Ltd., where he continues to innovate in the field of biotechnology. His work has the potential to impact therapeutic strategies significantly, particularly in the areas of immunotherapy and drug development.

Collaborations

Quan Du collaborates with Zicai Liang, a fellow researcher, to advance their work in RNA technology. Their combined expertise enhances the potential for groundbreaking discoveries in the field.

Conclusion

Quan Du's innovative work in RNA technology exemplifies the potential of biotechnology to transform medical treatments. His contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…